Dilaudid · DIN 00125083 · 2 mg · tablet
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Dilaudid · DIN 00125083
Manufacturer: Purdue Pharma; listing date 1996-10-01
Health Canada: Marketed since 2009-01-21 · brand DILAUDID · ATC N02AA03 HYDROMORPHONE · form Tablet · route Oral · ingredients HYDROMORPHONE HYDROCHLORIDE 2 MG · company Hargell (1998) inc. · schedule Narcotics (cdsa i)
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00125083)
Source record
DIN 00125083: Dilaudid
Raw flags: sec3=Y
Item: 280808018; group id 406; item number 0977; lccId None; manufacturer id PFP
Source form: Tab; strength: 2mg
Recorded listing: General benefit
Source prices (unrounded): $0.1565; ministry $0.1417
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00125083
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5939
Interchangeable products
Apo-Hydromorphone · DIN 02364123 · $0.1417
PMS-HYDROmorphone · DIN 00885436 · $0.1417
Teva-Hydromorphone · DIN 02319411 · $0.1417
Shortage status: not checked (no credentials)